Projects

Mgr. Kristína Jakič, PhD.

International

Finished
  • Epigenotoxicity of nanomaterials
    Program: Inter-academic agreement
    Duration: 1. 1. 2020 – 31. 12. 2022
  • Targeted combination therapy of colon cancer with therapeutic gene/drug loaded novel dendritic nanocarriers
    Program: Bilateral - other
    Duration: 3. 9. 2018 – 30. 11. 2022

National

Current
  • Comparison between silibinin-conjugated gold nanospheres and nanobipyramids impacts on the treatment of liver fibrosis in vivo.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Novel renal antisense therapy platform for CKD
    Program: SRDA
    Duration: 1. 8. 2021 – 30. 6. 2025
  • Diagnostic of oncological diseases using aptasensors: development and validation
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Preclinical validation of an innovative antisense platform for CML
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Preclinical validation of a SARS-CoV-2-specific RNA inhibitor
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2024
  • A pilot study of the selective effects of a new generation of RNA interfering agents at the cellular level
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Targeted inhibition of SARS-CoV-2 by a new generation RNA inhibitor
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
Employees